ArticleJournal of cellular biochemistry2020

Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels.

Mark Francis Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.